Ewald Wöll

3.0k total citations
56 papers, 1.3k citations indexed

About

Ewald Wöll is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ewald Wöll has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 11 papers in Surgery. Recurrent topics in Ewald Wöll's work include Gastric Cancer Management and Outcomes (22 papers), Colorectal Cancer Treatments and Studies (11 papers) and COVID-19 Clinical Research Studies (9 papers). Ewald Wöll is often cited by papers focused on Gastric Cancer Management and Outcomes (22 papers), Colorectal Cancer Treatments and Studies (11 papers) and COVID-19 Clinical Research Studies (9 papers). Ewald Wöll collaborates with scholars based in Austria, Germany and United States. Ewald Wöll's co-authors include Wolfgang Hilbe, Günter Weiß, Thomas Schmid, Eberhard Gunsilius, S Dirnhofer, Florian Lordick, Charlene M. Kahler, Rosa Bellmann‐Weiler, Sylvie Lorenzen and Gernot Fritsche and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Ewald Wöll

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewald Wöll Austria 19 535 476 280 272 231 56 1.3k
Wenze Wang China 19 252 0.5× 167 0.4× 67 0.2× 251 0.9× 118 0.5× 76 1.1k
Naoe Goto Japan 22 397 0.7× 190 0.4× 128 0.5× 199 0.7× 38 0.2× 66 1.2k
Lalitha Nayak United States 19 205 0.4× 142 0.3× 252 0.9× 839 3.1× 331 1.4× 57 2.0k
Nobuhiro Kanemura Japan 20 331 0.6× 146 0.3× 91 0.3× 248 0.9× 36 0.2× 70 1.0k
Susan Picton United Kingdom 26 320 0.6× 253 0.5× 438 1.6× 385 1.4× 28 0.1× 86 1.7k
Thomas Elter Germany 27 820 1.5× 395 0.8× 276 1.0× 185 0.7× 63 0.3× 68 2.4k
Guangchang Pei China 18 261 0.5× 147 0.3× 174 0.6× 306 1.1× 436 1.9× 35 1.3k
Richard Vinisko United States 15 212 0.4× 307 0.6× 81 0.3× 161 0.6× 75 0.3× 36 1.2k
F. Ries Luxembourg 21 622 1.2× 325 0.7× 199 0.7× 330 1.2× 20 0.1× 70 1.7k
Burhan Turgut Türkiye 19 217 0.4× 130 0.3× 86 0.3× 132 0.5× 165 0.7× 69 911

Countries citing papers authored by Ewald Wöll

Since Specialization
Citations

This map shows the geographic impact of Ewald Wöll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewald Wöll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewald Wöll more than expected).

Fields of papers citing papers by Ewald Wöll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewald Wöll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewald Wöll. The network helps show where Ewald Wöll may publish in the future.

Co-authorship network of co-authors of Ewald Wöll

This figure shows the co-authorship network connecting the top 25 collaborators of Ewald Wöll. A scholar is included among the top collaborators of Ewald Wöll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewald Wöll. Ewald Wöll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Widmann, Gerlig, Anna Luger, Thomas Sonnweber, et al.. (2025). Machine Learning Based Multi-Parameter Modeling for Prediction of Post-Inflammatory Lung Changes. Diagnostics. 15(6). 783–783. 1 indexed citations
2.
Ilhan‐Mutlu, Aysegül, Florian Lordick, & Ewald Wöll. (2025). Zolbetuximab and the novel biomarker claudin 18.2 in the treatment of gastroesophageal adenocarcinoma. memo - Magazine of European Medical Oncology. 18(4). 264–271.
3.
Lordick, Florian, Salah‐Eddin Al‐Batran, Dirk Arnold, et al.. (2023). German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer. Gastric Cancer. 27(1). 6–18. 3 indexed citations
4.
Sonnweber, Thomas, Alex Pizzini, Anna Boehm, et al.. (2023). Pulmonary recovery from COVID-19 in patients with metabolic diseases: a longitudinal prospective cohort study. Scientific Reports. 13(1). 2599–2599. 3 indexed citations
5.
Wöll, Ewald, Arno Amann, Wolfgang Eisterer, et al.. (2023). Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy – An Update. Anticancer Research. 43(7). 2889–2897. 2 indexed citations
6.
Ilhan‐Mutlu, Aysegül & Ewald Wöll. (2023). Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma. memo - Magazine of European Medical Oncology. 16(4). 237–241.
7.
Taghizadeh, Hossein, Angela Djanani, Wolfgang Eisterer, et al.. (2023). Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement. Frontiers in Oncology. 13. 1225154–1225154. 2 indexed citations
8.
Sonnweber, Thomas, Piotr Tymoszuk, Sabina Sahanic, et al.. (2022). Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial. eLife. 11. 27 indexed citations
9.
Sonnweber, Thomas, Sabina Sahanic, Alex Pizzini, et al.. (2022). The Impact of Iron Dyshomeostasis and Anaemia on Long-Term Pulmonary Recovery and Persisting Symptom Burden after COVID-19: A Prospective Observational Cohort Study. Metabolites. 12(6). 546–546. 17 indexed citations
10.
Luger, Anna, Thomas Sonnweber, Leonhard Gruber, et al.. (2022). Chest CT of Lung Injury 1 Year after COVID-19 Pneumonia: The CovILD Study. Radiology. 304(2). 462–470. 57 indexed citations
11.
Wöll, Ewald, et al.. (2021). A presumed extragonadal germ cell tumor that turned out to be a gastric cancer—a case report. Translational Andrology and Urology. 10(6). 2528–2533. 2 indexed citations
12.
Huber, Daniela, Christina Pichler, Ewald Wöll, et al.. (2019). Green exercise and mg-ca-SO4 thermal balneotherapy for the treatment of non-specific chronic low back pain: a randomized controlled clinical trial. BMC Musculoskeletal Disorders. 20(1). 221–221. 36 indexed citations
13.
14.
Bokemeyer, Carsten, Alexander Stein, Karsten Ridwelski, et al.. (2014). A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer. Gastric Cancer. 18(4). 833–42. 16 indexed citations
15.
Gabriel, Michael, Clemens Decristoforo, Ewald Wöll, et al.. (2011). [ 99m Tc]Demotensin VI: Biodistribution and Initial Clinical Results in Tumor Patients of a Pilot/Phase I Study. Cancer Biotherapy and Radiopharmaceuticals. 26(5). 557–563. 13 indexed citations
16.
Lordick, Florian, Birgit Luber, Sylvie Lorenzen, et al.. (2010). Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). British Journal of Cancer. 102(3). 500–505. 141 indexed citations
17.
Arnold, Dirk, Thomas Höhler, Christian Dittrich, et al.. (2008). Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group. Annals of Oncology. 19(8). 1442–1449. 45 indexed citations
18.
Auberger, Jutta, et al.. (2005). Increased CD133 expression in bone marrow of myelodysplastic syndromes. Leukemia Research. 29(9). 995–1001. 7 indexed citations
19.
20.
Lhotta, Karl, Thomas Kühr, Hans J. Rumpelt, et al.. (1999). Thrombotic Microangiopathy with Renal Failure in Two Patients Undergoing Gemcitabine Chemotherapy. American Journal of Nephrology. 19(5). 590–593. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenze Wang Breakdown of academic impact, for papers by Naoe Goto Breakdown of academic impact, for papers by Lalitha Nayak Breakdown of academic impact, for papers by Nobuhiro Kanemura Breakdown of academic impact, for papers by Susan Picton Breakdown of academic impact, for papers by Thomas Elter Breakdown of academic impact, for papers by Guangchang Pei Breakdown of academic impact, for papers by Richard Vinisko Breakdown of academic impact, for papers by F. Ries Breakdown of academic impact, for papers by Burhan Turgut
Rankless by CCL
2026